Francisco Javier Benitez-Rodríguez

Francisco Javier Benitez-Rodríguez

Auto-generated profile, based on publicly available information

Francisco Javier Benitez-Rodríguez

Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl Siglo XXI, Inst Mexicano Seguro Social IMSS, Serv Endocrinol,Unidad Invest Endocrinas, Ciudad De Mexico, Mexico

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
GVGuadalupe Vargas-Ortega
Guadalupe Vargas-Ortega
BGBaldomero José Gregorio González-Virla
Baldomero José Gregorio González-Virla
LBLourdes Balcázar-Hernandez
Lourdes Balcázar-Hernandez
RARocío Arreola-Rosales
Rocío Arreola-Rosales
FBFrancisco Javier Benitez-Rodríguez
Francisco Javier Benitez-Rodríguez
MMMoises Mercado
Moises Mercado
Objective: To evaluate the response to cabergoline (CBG) treatment in patients with non-functioning pituitary adenomas (NFPA). Subjects and methods: Retrospective, single tertiary care center study. A total of 44 patients were treated with 3 mg/week of CBG, 32 after surgical treatment (transsphenoidal surgery [TSS] in 27 and TC in 5 patients) and 12 as primary therapy. Mean age was 59.2 ± 12 years and 23 (52.2%) were women. Response to therapy was ascertained by serial magnetic resonance imaging. The [...] ABSTRACT Objective: To evaluate the response to cabergoline (CBG) treatment in patients with non-functioning pituitary adenomas (NFPA). Subjects and methods: Retrospective, single tertiary care center study. A total of 44 patients were treated with 3 mg/week of CBG, 32 after surgical treatment (transsphenoidal surgery [TSS] in 27 and TC in 5 patients) and 12 as primary therapy. Mean age was 59.2 ± 12 years and 23 (52.2%) were women. Response to therapy was ascertained by serial magnetic resonance imaging. The